Abstract:Fifteen new polyprenylated acylphloroglucinols (1—15, PPAPs), along with 36 known PPAP derivatives were obtained from Hypericum kouytchense. Compound 1 was a rare PPAP with a fused 6/6/6/5/5 pentacyclic ring system. The primary mechanistic study of compound 34, implied that this compound could prohibit the function of P‐gp transport rather than its expression. Comprehensive Summary Given the lack of systematic polyprenylated acylphloroglucinols (PPAPs) research on traditional Chinese medicine of Hypericum kouytchense, this plant was applied for the phytochemical study, which led to fifteen new PPAPs (1—15, PPAPs), along with 36 known PPAP derivatives. Their structures and absolute configurations were established by comprehensive spectral analysis and theoretical ECD and NMR calculations. Structurally, compound 1 possesses a rare fused 6/6/6/5/5 pentacyclic ring system. Eleven compounds exhibited good multidrug resistance reversal activity (RF ranging from 5 to 53) in HepG2/ADR cells. Importantly, compound 34, the most potential MDR modulator, showed better reversal effect (RF: 53) than positive control, verapamil. The primary mechanistic study of compound 34, implied that this compound could prohibit the function of P‐gp transport rather than its expression. The possible recognition mechanism between compound 34 and P‐gp was predicted by molecular docking.

Polyprenylated acylphloroglucinols as deubiquitinating protease USP7 inhibitors from Hypericum hookerianum

Polycyclic polyprenylated acylphloroglucinols from Hypericum beanii and their hepatoprotective activity

Hyperkouytones A—O, New Polyprenylated Acylphloroglucinols from Hypericum kouytchense with Multidrug Resistance Reversal Activity

Polyprenylated acylphloroglucinol meroterpenoids with PTP1B inhibition from Hypericum forrestii

Diverse polycyclic polyprenylated acylphloroglucinols with anti-neuroinflammatory activity from Hypericum beanii

Kiiacylphnols A−H, eight undescribed polycyclic polyprenylated acylphloroglucinols with anticancer activities from Hypericum przewalskii Maxim

Discovery of Bioactive Polycyclic Polyprenylated Acylphloroglucinols from Hypericum Wilsonii.

Hyperforatins L-U: Prenylated Acylphloroglucinols with a Terminal Double Bond from Hypericum Perforatum L. (st John's Wort).

Discovery of 13,15-nor-polycyclic Polyprenylated Acylphloroglucinols from Hypericum Longistylum with Anti-Inflammatory Activity.

Type B polycyclic polyprenylated acylphloroglucinols from the roots of Hypericum beanii

Hyperispirones A and B, Spiro-Bridged Polycyclic Polyprenylated Acylphloroglucinols with Anti-Angiogenesis Activity from Hypericum Beanii

Polycyclic Polyprenylated Acylphloroglucinols and Chromone O-glucosides from Hypericum Henryi Subsp. Uraloides.

Seco-polyprenylated Acylphloroglucinols from Hypericum Elodeoides Induced Cell Cycle Arrest and Apoptosis in MCF-7 Cells Via Oxidative DNA Damage

Hyparillums A and B: polycyclic polyprenylated acylphloroglucinols from Hypericum patulum

New polycyclic polyprenylated acylphloroglucinols with antidepressant activities from Hypericum perforatum L.

Hyperfols A and B: Two Highly Modified Polycyclic Polyprenylated Acylphloroglucinols from Hypericum perforatum

Hyperpatulones C-G, new spirocyclic polycyclic polyprenylated acylphloroglucinols from the leaves of Hypericum patulum

Anti-adipogenicadamantane type polycyclic polyprenylated acylphloroglucinols from Hypericum subsessile

Hyperbenzones A and B, two 1,2-seco and rearranged polycyclic polyprenylated acylphloroglucinols from Hypericum beanii

Polyprenylated acylphloroglucinols from Hypericum sampsonii with cytotoxicity against pancreatic carcinomas

Polycyclic Polyprenylated Acylphloroglucinol Congeners Possessing Diverse Structures from Hypericum Henryi